Literature DB >> 9639792

Induction of osteocalcin gene expression in vitro by progesterone.

L Chen1, N T Foged.   

Abstract

The effect of progesterone on osteocalcin gene expression was investigated in order to understand how progesterone acts on osteoblast in vitro. For this purpose, fetal rat calvarial osteoblasts were cultured in the medium containing 10(-9) M-10(-6) M progesterone respectively for two weeks while the cells progressing differentiation. Northern blot analysis showed that progesterone increased the level of osteocalcin mRNA in a dose-dependent manner. Among those doses of progesterone employed in this study, only 10(-6) M hormone caused a significant induction of osteocalcin gene expression (2.3 fold, P < 0.01). Our results demonstrated for the first time that the osteocalcin gene expression is regulated by progesterone. In addition, the results obtained from our study provides a good evidence for the direct effect of progesterone on osteoblast in vitro.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9639792     DOI: 10.1007/bf02888237

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  7 in total

1.  ALP induction by beta-glycerophosphate during the non-mineralization phase in vitro.

Authors:  L Chen; J Schøller; N T Foged
Journal:  J Tongji Med Univ       Date:  1996

2.  Differentiation of osteoblast in vitro is regulated by progesterone.

Authors:  L Chen; N T Foged
Journal:  J Tongji Med Univ       Date:  1996

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro.

Authors:  B A Scheven; C A Damen; N J Hamilton; H J Verhaar; S A Duursma
Journal:  Biochem Biophys Res Commun       Date:  1992-07-15       Impact factor: 3.575

5.  Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis.

Authors:  C Christiansen; B J Riis; L Nilas; P Rødbro; L Deftos
Journal:  Lancet       Date:  1985-10-12       Impact factor: 79.321

6.  Prevention of bone mineral loss in postmenopausal women by norethisterone.

Authors:  H I Abdalla; D M Hart; R Lindsay; I Leggate; A Hooke
Journal:  Obstet Gynecol       Date:  1985-12       Impact factor: 7.661

7.  Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants.

Authors:  J Glowacki; J B Lian
Journal:  Cell Differ       Date:  1987-09
  7 in total
  1 in total

1.  Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice.

Authors:  Wei Yao; Weiwei Dai; Mohammad Shahnazari; Aaron Pham; Zhiqiang Chen; Haiyan Chen; Min Guan; Nancy E Lane
Journal:  PLoS One       Date:  2010-07-01       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.